We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDER: BETTER NME APPLICATIONS COULD SPEED DRUG APPROVALS
CDER: BETTER NME APPLICATIONS COULD SPEED DRUG APPROVALS
June 16, 2004
The FDA is stepping up its efforts to get pharmaceutical companies to submit more complete applications for new molecular entities (NMEs) — an action the agency believes could expedite the drug approval process.